These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6698352)

  • 1. Serum group I pepsinogens level in cystic fibrosis.
    Sategna-Guidetti C; de Candussio G; di Napoli A; Peyre S; Franchi D; Santini B; Castello D
    Gastroenterol Clin Biol; 1984 Feb; 8(2):141-4. PubMed ID: 6698352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
    Samloff IM
    Gastroenterology; 1982 Jan; 82(1):26-33. PubMed ID: 7053333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
    Hengels KJ; Strohmeyer G
    Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis.
    Uhlenbruck G; Scheuring U; Dienst C; Kaiser D; Roth B; Skopnik H
    Klin Padiatr; 1988; 200(2):89-95. PubMed ID: 3164430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
    Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y
    Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
    Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
    Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium and glutathione peroxidase levels in cystic fibrosis.
    Lloyd-Still JD; Ganther HE
    Pediatrics; 1980 May; 65(5):1010-2. PubMed ID: 7367113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoreactive trypsin in cystic fibrosis.
    Burlina A; Rizzotti P; Tonon M; Mastella G
    Scand J Gastroenterol Suppl; 1980; 62():35-43. PubMed ID: 6935754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group I pepsinogens in serum. I. Normal range, age and sex relation, diurnal rhythm, seasonal variation, and distribution in ABO blood groups.
    Axelsson CK; Szecsi PB; Nielsen MD
    Scand J Gastroenterol; 1984 Nov; 19(8):1114-8. PubMed ID: 6549484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and provocative tests for gastroduodenal disorders.
    Walsh JH
    J Clin Gastroenterol; 1981; 3(Suppl 2):73-8. PubMed ID: 7320472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Fetoprotein and cystic fibrosis.
    Beaudry PH; Bergsteinsson H; Dupont C; Wong HC; Shuster J; Desmond K; Gold P
    Clin Invest Med; 1982; 5(1):45-7. PubMed ID: 6180858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
    Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
    Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin and cytokines in whole blood in relation to clinical and nutritional status in cystic fibrosis.
    Schmitt-Grohé S; Hippe V; Igel M; von Bergmann K; Posselt HG; Krahl A; Smaczny C; Wagner TO; Nikolaizik W; Lentze MJ; Zielen S
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):228-33. PubMed ID: 16877990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of serum pepsinogen in relation to gastric (pars oesophagea) ulceration in swine herds.
    Nappert G; Vrins A; Beauregard M; Vermette L; Larivière N
    Can J Vet Res; 1990 Jun; 54(3):390-3. PubMed ID: 2379118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y; Shinomura Y; Kanayama S; Miyazaki Y; Bonilla Palacios JJ; Matsuzawa Y
    Ital J Gastroenterol; 1996; 28(8):457-61. PubMed ID: 9032589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary epidermal growth factor and serum pepsinogen I in patients with duodenal ulcers].
    Kolster J; de Kolster CC; Carvajal A; Castro J; González E; Brasel JA; Callegari C
    G E N; 1993; 47(1):16-21. PubMed ID: 8243967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.